In the last session of trading, Clovis Oncology, Inc. (NASDAQ:CLVS) shares changed -0.68%. Sell-side analysts covering the company are looking for the stock to go to $35.00 within the next 52 weeks. Target prices can vary greatly depending on the analyst providing projections. This target is the consensus price coming from analysts polled by Thomson Reuters.
Analysts and investors may use different metrics in order to calculate a price target projection. A very common metric used is the price to earnins ratio of a company. This calculation comes from dividing the current share price by the projected earnings per share. At the time of writing, Clovis Oncology, Inc. has a P/E Ratio of N/A. Investors may also examine a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A company with a PEG Ratio below one may be seen as undervalued while a PEG Ratio above one may signal that the company is overvalued. A PEG Ratio close to one may be considered to be fair value. Currently, the stock has a PEG Ratio of 0.00.
Let’s take a quick look at stock performance. Shares are currently trading $4.21 away from the 50-day moving average of $32.33 and $14.02 away from the 200-day moving average of $22.52. Shares are currently trading -9.31% away from the 52-week high price of 40.29 and +215.82% off the 52-week low of 11.57. Keeping an eye on the stock price relative to moving averages and yearly highs/lows may help evaluate future stock value.